These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 12131295

  • 1. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
    Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR.
    J Urol; 2002 Aug; 168(2):491-5. PubMed ID: 12131295
    [Abstract] [Full Text] [Related]

  • 2. Prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR, CaPSURE Investigators.
    Brachytherapy; 2007 Aug; 6(2):123-8. PubMed ID: 17434105
    [Abstract] [Full Text] [Related]

  • 3. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
    Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR.
    J Urol; 2005 May; 173(5):1557-61. PubMed ID: 15821485
    [Abstract] [Full Text] [Related]

  • 4. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR.
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [Abstract] [Full Text] [Related]

  • 5. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [Abstract] [Full Text] [Related]

  • 6. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
    Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR, CaPSURE Investigators.
    J Urol; 2006 Oct; 176(4 Pt 1):1382-6. PubMed ID: 16952638
    [Abstract] [Full Text] [Related]

  • 7. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
    Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, CaPSURE Investigators.
    J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
    [Abstract] [Full Text] [Related]

  • 8. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Cancer; 2006 Apr 15; 106(8):1708-14. PubMed ID: 16544313
    [Abstract] [Full Text] [Related]

  • 9. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.
    J Urol; 2007 Nov 15; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
    Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR.
    J Urol; 2005 Mar 15; 173(3):732-6. PubMed ID: 15711258
    [Abstract] [Full Text] [Related]

  • 13. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May 15; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct 15; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

  • 19. Impact of increased number of biopsies on the nature of prostate cancer identified.
    Meng MV, Elkin EP, DuChane J, Carroll PR.
    J Urol; 2006 Jul 15; 176(1):63-8; discussion 69. PubMed ID: 16753368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.